Immix Biopharma Balance Sheet (2020-2026) | IMMX

Balance Sheet Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation (Quarter) 0.01M
Assets
Current Assets
Cash & Equivalents (Quarter) 0.39M17.64M19.06M18.40M16.92M13.44M11.46M12.65M19.58M17.51M29.32M23.98M19.69M17.68M15.92M11.60M15.95M93.93M79.25M232.10M
Prepaid Assets (Quarter) 0.01M0.52M0.89M0.52M0.29M0.08M1.25M2.56M2.10M0.26M0.19M0.15M0.04M0.01M0.17M0.69M0.05M0.18M0.34M1.68M
Current Assets (Quarter) 0.53M18.19M20.01M19.08M17.39M14.90M13.03M15.51M22.33M19.79M32.92M27.33M22.76M20.20M16.78M12.33M16.58M101.24M92.27M233.79M
Non-Current Assets
Construction in Progress (Quarter) 0.31M
Property, Plant & Equipment (Net) (Quarter) 0.01M0.01M0.01M0.00M0.00M0.00M0.05M0.00M0.04M0.05M0.36M0.36M0.84M1.74M0.95M1.04M2.36M2.52M2.43M2.36M
Long-Term Deferred Tax (Quarter) 0.01M0.09M0.11M0.11M0.09M0.16M
Long-Term Investments (Quarter) 2.10M
Other Non-Current Assets (Quarter) 0.02M
Non-Current Assets (Quarter) 5.32M
Assets (Quarter) 239.11M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 9.19M
Notes Payables (Quarter) 0.05M0.05M0.05M
Payables (Quarter) 9.19M
Accumulated Expenses (Quarter) 0.17M
Short term Debt (Quarter) 4.05M
Current Leases (Quarter) 0.11M
Total Current Liabilities (Quarter) 9.30M
Non-Current Liabilities
Minority Interest (Quarter) -0.03M-0.06M-0.12M-0.20M-0.28M
Operating Leases (Quarter) 0.89M
Other Non-Current Liabilities (Quarter) 0.57M23.41M
Total Non-Current Liabilities (Quarter) 4.70M-23.21M1.75M3.72M6.72M4.94M7.59M9.70M
Total Liabilities (Quarter) 10.19M
Shareholder's Equity
Total Debt (Quarter) 4.05M
Common Equity (Quarter) 228.92M
Liabilities and Shareholders Equity (Quarter) 239.11M
Treasury Shares (Quarter) 0.07M
Retained Earnings (Quarter) 355.00M